Kamada Ltd.
DRY POWDER FORMULATIONS OF ALPHA-1 ANTITRYPSIN
Last updated:
Abstract:
Dry powder formulations comprising AAT and methods of using thereof are provided. Said formulations comprise AAT molecules in their monomelic form and excipients which are highly suitable for inhalation administering.
Status:
Application
Type:
Utility
Filling date:
20 Dec 2017
Issue date:
25 Mar 2021